MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY

MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY

Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL, MER or Tyro3 protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FUH, KATHERINE, RANKIN, ERINN BRUNO, MIAO, YU, KARIOLIS, MIHALIS, GIACCIA, AMATO J, JONES, DOUGLAS, HERSHENSON, SUSAN, COCHRAN, JENNIFER R
Format: Patent
Sprache:eng ; fre
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL, MER or Tyro3 protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL, MER or Tyro3 and its ligand GAS6. L'invention concerne des compositions et des procédés qui permettent d'atténuer un cancer, chez un mammifère, par l'administration d'une dose thérapeutique d'une composition pharmaceutique qui inhibe l'activité d'AXL, de MER ou de l'activité de la protéine Tyro3, par exemple par l'inhibition compétitive ou non compétitive de l'interaction de liaison entre AXL, MER ou Tyro3 et son ligand GAS6.